This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monitto, C. L. Articles by Sidransky, D. Search for Related Content PubMed PubMed Citation Articles by Monitto, C. L. Articles by Sidransky, D.

Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia

Departments of ¹ Anesthesiology and Critical Care Medicine and ² Otolaryngology-Head and Neck Surgery, The Johns Hopkins Hospital, Baltimore, Maryland, and ³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland

Cachexia is an important cause of secondary morbidity and mortality in patients with cancer. Previous studies have suggested that cancer-associated cachexia may be due in part to tumor-specific production and secretion of a glycosylated peptide, proteolysis-inducing factor, originally identified in a murine cancer cachexia model. We report here the cloning of a human cDNA that generates a peptide having high-sequence homology to this proteolysis-inducing factor. Constitutive expression of human proteolysis-inducing factor is low or absent in most normal human tissues but appears to be elevated in some human tumors. Stable forced expression of human proteolysis-inducing factor in multiple murine and human cell lines results in a secreted protein, but no glycosylation of the protein is detected. In addition, tumor xenografts engineered to overexpress human proteolysis-inducing factor protein do not induce cachexia in vivo. These findings raise important questions as to potential cross-species differences in protein sequence and processing of murine proteolysis-inducing factor and human proteolysis-inducing factor, as well as the nature of the relationship between human proteolysis-inducing factor and the development of cancer cachexia.

This article has been cited by other articles:

				M. J. Tisdale Mechanisms of Cancer Cachexia Physiol Rev, April 1, 2009; 89(2): 381 - 410. [Abstract] [Full Text] [PDF]

				K.-A. Kim, S.-O Ka, W. S. Moon, H.-K. Yi, Y.-H. Lee, K.-B. Kwon, J.-W. Park, and B.-H. Park Effect of dermcidin, an antimicrobial peptide, on body fat mobilization in normal mice J. Endocrinol., July 1, 2008; 198(1): 111 - 118. [Abstract] [Full Text] [PDF]

				V. E. Baracos Reply to Letter to the Editor: a Response to the Letter of M. Tisdale Clin. Cancer Res., April 1, 2008; 14(7): 2245 - 2245. [Full Text] [PDF]

				P. T. Todorov, S. M. Wyke, and M. J. Tisdale Identification and Characterization of a Membrane Receptor for Proteolysis-Inducing Factor on Skeletal Muscle Cancer Res., December 1, 2007; 67(23): 11419 - 11427. [Abstract] [Full Text] [PDF]

				B. M. Wieland, G. D. Stewart, R. J.E. Skipworth, K. Sangster, K. C.H. Fearon, J. A. Ross, T. J. Reiman, J. Easaw, M. Mourtzakis, V. Kumar, et al. Is There a Human Homologue to the Murine Proteolysis-Inducing Factor? Clin. Cancer Res., September 1, 2007; 13(17): 4984 - 4992. [Abstract] [Full Text] [PDF]